These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 29843752

  • 1. Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease.
    Gerum S, Heinz C, Belka C, Walter F, Paprottka P, De Toni EN, Roeder F.
    Radiat Oncol; 2018 May 29; 13(1):100. PubMed ID: 29843752
    [Abstract] [Full Text] [Related]

  • 2. Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment setting.
    Gerum S, Heinz C, Belka C, Walter F, Paprottka PM, De Toni EN, Roeder F.
    Strahlenther Onkol; 2020 Apr 29; 196(4):334-348. PubMed ID: 31732784
    [Abstract] [Full Text] [Related]

  • 3. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
    Scorsetti M, Comito T, Cozzi L, Clerici E, Tozzi A, Franzese C, Navarria P, Fogliata A, Tomatis S, D'Agostino G, Iftode C, Mancosu P, Ceriani R, Torzilli G.
    J Cancer Res Clin Oncol; 2015 Jul 29; 141(7):1301-9. PubMed ID: 25644863
    [Abstract] [Full Text] [Related]

  • 4. Stereotactic body radiation therapy for centrally located hepatocellular carcinoma: outcomes and toxicities.
    Lazarev S, Hardy-Abeloos C, Factor O, Rosenzweig K, Buckstein M.
    J Cancer Res Clin Oncol; 2018 Oct 29; 144(10):2077-2083. PubMed ID: 30088143
    [Abstract] [Full Text] [Related]

  • 5. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
    Huang WY, Jen YM, Lee MS, Chang LP, Chen CM, Ko KH, Lin KT, Lin JC, Chao HL, Lin CS, Su YF, Fan CY, Chang YW.
    Int J Radiat Oncol Biol Phys; 2012 Oct 01; 84(2):355-61. PubMed ID: 22342300
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma - Initial Experience From an Australian Liver Cancer Service.
    Liu HY, Lee Y, McLean K, Leggett D, Hodgkinson P, Fawcett J, Mott R, Stuart K, Pryor D.
    Clin Oncol (R Coll Radiol); 2020 Oct 01; 32(10):e194-e202. PubMed ID: 32345457
    [Abstract] [Full Text] [Related]

  • 7. Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma.
    Gkika E, Schultheiss M, Bettinger D, Maruschke L, Neeff HP, Schulenburg M, Adebahr S, Kirste S, Nestle U, Thimme R, Grosu AL, Brunner TB.
    Radiat Oncol; 2017 Jul 12; 12(1):116. PubMed ID: 28701219
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
    Long Y, Liang Y, Li S, Guo J, Wang Y, Luo Y, Wu Y.
    Radiat Oncol; 2021 Apr 08; 16(1):68. PubMed ID: 33832536
    [Abstract] [Full Text] [Related]

  • 9. Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasion.
    Mathew AS, Atenafu EG, Owen D, Maurino C, Brade A, Brierley J, Dinniwell R, Kim J, Cho C, Ringash J, Wong R, Cuneo K, Feng M, Lawrence TS, Dawson LA.
    Eur J Cancer; 2020 Jul 08; 134():41-51. PubMed ID: 32460180
    [Abstract] [Full Text] [Related]

  • 10. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.
    Méndez Romero A, Wunderink W, Hussain SM, De Pooter JA, Heijmen BJ, Nowak PC, Nuyttens JJ, Brandwijk RP, Verhoef C, Ijzermans JN, Levendag PC.
    Acta Oncol; 2006 Jul 08; 45(7):831-7. PubMed ID: 16982547
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients.
    Sanuki N, Takeda A, Oku Y, Mizuno T, Aoki Y, Eriguchi T, Iwabuchi S, Kunieda E.
    Acta Oncol; 2014 Mar 08; 53(3):399-404. PubMed ID: 23962244
    [Abstract] [Full Text] [Related]

  • 13. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
    Nakamura M, Hashimoto N, Mayahara H, Uezono H, Harada A, Nishikawa R, Matsuo Y, Kawaguchi H, Nishimura H.
    Radiat Oncol; 2018 Apr 23; 13(1):75. PubMed ID: 29688858
    [Abstract] [Full Text] [Related]

  • 14. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.
    Goodman KA, Wiegner EA, Maturen KE, Zhang Z, Mo Q, Yang G, Gibbs IC, Fisher GA, Koong AC.
    Int J Radiat Oncol Biol Phys; 2010 Oct 01; 78(2):486-93. PubMed ID: 20350791
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience.
    Francolini G, Desideri I, Detti B, Di Cataldo V, Masi L, Caramia G, Visani L, Terziani F, Muntoni C, Lo Russo M, Loi M, Livi L.
    Cancer Treat Res Commun; 2019 Oct 01; 19():100124. PubMed ID: 30851645
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases.
    Fumagalli I, Bibault JE, Dewas S, Kramar A, Mirabel X, Prevost B, Lacornerie T, Jerraya H, Lartigau E.
    Radiat Oncol; 2012 Sep 27; 7():164. PubMed ID: 23014094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.